Daniel M. Bendheim, Executive VP, Corporate Strategy at PHIBRO ANIMAL HEALTH CORP (PAHC), sold 9,780 shares at $31.55 ($306K) on 2019-01-28, disclosed to the SEC on 2019-01-30.
Open-market sale of $306k PAHC by Executive VP, Corporate Strategy. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $31.55 | 2,500 | $79K | 25.7% |
| 2 | $31.32 | 4,890 | $153K | 50.0% |
| 3 | $31.15 | 2,390 | $74K | 24.3% |
| Total | $31.34 avg | 9,780 | $306K | 100% |
| Filing → |
| PAHC | SELL | 2019-01-10 | $162K | — | Filing → |
| PAHC | SELL | 2019-01-07 | $238K | — | Filing → |
| PAHC | SELL | 2018-09-14 | $111K | — | Filing → |